|
US4394448A
(en)
|
1978-02-24 |
1983-07-19 |
Szoka Jr Francis C |
Method of inserting DNA into living cells
|
|
US4529561A
(en)
|
1978-03-24 |
1985-07-16 |
The Regents Of The University Of California |
Method for producing liposomes in selected size range
|
|
US4241046A
(en)
|
1978-11-30 |
1980-12-23 |
Papahadjopoulos Demetrios P |
Method of encapsulating biologically active materials in lipid vesicles
|
|
US4925661A
(en)
|
1984-04-19 |
1990-05-15 |
Leaf Huang |
Target-specific cytotoxic liposomes
|
|
US4957735A
(en)
|
1984-06-12 |
1990-09-18 |
The University Of Tennessee Research Corporation |
Target-sensitive immunoliposomes- preparation and characterization
|
|
US4755388A
(en)
|
1984-11-09 |
1988-07-05 |
The Regents Of The University Of California |
Liposome-encapsulated 5-fluoropyrimidines and methods for their use
|
|
DE3542773A1
(de)
|
1985-12-04 |
1987-06-11 |
Roehm Pharma Gmbh |
Hautwirksame pharmaka mit liposomen als wirkstofftraeger
|
|
US4828837A
(en)
|
1987-03-30 |
1989-05-09 |
Liposome Technology, Inc. |
Non-crystalline minoxidil composition, its production and application
|
|
US5077211A
(en)
|
1988-07-06 |
1991-12-31 |
Applied Genetics, Inc. |
Purification and administration of dna repair enzymes
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
US5043164A
(en)
|
1989-01-17 |
1991-08-27 |
The University Of Tennessee Research Corporation |
Blood-stable, cholesterol-free liposomes
|
|
US5064655A
(en)
|
1989-02-24 |
1991-11-12 |
Liposome Technology, Inc. |
Liposome gel composition and method
|
|
US5744101A
(en)
|
1989-06-07 |
1998-04-28 |
Affymax Technologies N.V. |
Photolabile nucleoside protecting groups
|
|
US5264618A
(en)
|
1990-04-19 |
1993-11-23 |
Vical, Inc. |
Cationic lipids for intracellular delivery of biologically active molecules
|
|
EP0532767B1
(en)
|
1991-04-05 |
1997-03-05 |
Kanegafuchi Kagaku Kogyo Kabushiki Kaisha |
3-Phenoxybenzyl(idene)pyrrolidine derivatives, their preparation and their use as muscarinic cholinergic agents
|
|
US5491069A
(en)
|
1994-02-18 |
1996-02-13 |
The Regents Of The University Of California |
Biomarkers of cell senescence
|
|
US5888764A
(en)
|
1995-01-20 |
1999-03-30 |
Uab Research Foundation |
Human fas gene promoter region
|
|
DE19713393C2
(de)
|
1997-04-01 |
2002-12-05 |
Apotech Res & Dev Ltd |
Flip-Gen und Flip-Protein
|
|
JPH11349568A
(ja)
|
1998-06-08 |
1999-12-21 |
Maruho Co Ltd |
ラクタム誘導体及びその医薬用途
|
|
EP1100496A4
(en)
*
|
1998-07-21 |
2002-10-23 |
Univ Jefferson |
SMALL MOLECULES INHIBIT THE BCL-2 PROTEINS
|
|
AUPR038200A0
(en)
|
2000-09-26 |
2000-10-19 |
Beta Peptide Foundation Pty Ltd, The |
Compositions and methods for delaying, preventing, rejuvenating or reversing senescence
|
|
AU2002305769B2
(en)
|
2001-05-30 |
2007-07-19 |
Georgetown University |
Small molecule antagonists of Bcl2 family proteins
|
|
ES2327773T3
(es)
|
2002-05-07 |
2009-11-03 |
Institut Pasteur |
Seleccion de peptidos que unhiben la union de pp1c a proteinas bcl-2, bcl-xl y bcl-w.
|
|
WO2004066915A2
(en)
|
2003-01-23 |
2004-08-12 |
The Trustees Of Columbia University In The City Of New York |
Old-35, a gene associated with senescence and terminal cell differentiation, and uses thereof
|
|
CN1832939B
(zh)
|
2003-05-30 |
2010-04-28 |
杰明X医药品加拿大公司 |
用于治疗癌症或病毒病的三杂环化合物、组合物和方法
|
|
WO2005042002A2
(en)
|
2003-10-30 |
2005-05-12 |
Entelos, Inc. |
Treatment of rhematoid arthritis with flip antagonists
|
|
US7973161B2
(en)
|
2003-11-13 |
2011-07-05 |
Abbott Laboratories |
Apoptosis promoters
|
|
CN101208437B
(zh)
|
2003-12-12 |
2012-07-04 |
圣路易斯大学 |
检测大分子和其它分析物的生物传感器
|
|
MY149038A
(en)
|
2004-05-26 |
2013-07-15 |
Eisai R&D Man Co Ltd |
Cinnamide compound
|
|
CA2577752A1
(en)
|
2004-08-20 |
2006-03-02 |
The Regents Of The University Of Michigan |
Small molecule inhibitors of anti-apoptotic bcl-2 family members and the uses thereof
|
|
US7533068B2
(en)
|
2004-12-23 |
2009-05-12 |
D-Wave Systems, Inc. |
Analog processor comprising quantum devices
|
|
EP1888550B1
(en)
|
2005-05-12 |
2014-06-25 |
AbbVie Bahamas Ltd. |
Apoptosis promoters
|
|
US20100093613A1
(en)
|
2007-03-09 |
2010-04-15 |
Kunkel Eric J |
Methods for identifying agents and their use for the prevention or stabilization of fibrosis
|
|
CA2682483A1
(en)
|
2007-03-29 |
2008-10-09 |
Novartis Ag |
3-imidazolyl-indoles for the treatment of proliferative diseases
|
|
US20100310504A1
(en)
|
2007-09-26 |
2010-12-09 |
Lowe Scott W |
Methods for treating fibrosis by modulating cellular senescence
|
|
US20120156134A1
(en)
|
2007-12-20 |
2012-06-21 |
Shayne Squires |
Compositions and methods for detecting or eliminating senescent cells to diagnose or treat disease
|
|
CA2718400A1
(en)
|
2008-03-11 |
2009-09-17 |
The General Hospital Corporation |
Piperlongumine and piperlongumine analogs for use in the treatment of cancer
|
|
US8168784B2
(en)
|
2008-06-20 |
2012-05-01 |
Abbott Laboratories |
Processes to make apoptosis promoters
|
|
US20100086941A1
(en)
|
2008-10-01 |
2010-04-08 |
Adami Guy R |
Methods for determining aged based accumulation of senescent cells using senescence specific DNA damage markers
|
|
RU2561109C2
(ru)
|
2008-12-19 |
2015-08-20 |
Дженентек, Инк. |
Соединения и способы применения
|
|
US8232273B2
(en)
|
2008-12-19 |
2012-07-31 |
Genentech, Inc. |
Heterocyclic compounds and methods of use
|
|
BRPI1016102A2
(pt)
|
2009-04-15 |
2015-09-01 |
Sanford Burhnham Medical Res Inst |
Inibidores de proteínas anti-apoptótica baseados em naftaleno
|
|
NZ595708A
(en)
|
2009-05-26 |
2014-03-28 |
Abbvie Bahamas Ltd |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
|
|
EP2289528A1
(en)
|
2009-07-21 |
2011-03-02 |
DSM IP Assets B.V. |
Novel nutraceutical compositions containing black pepper or its constituents improving mental performance
|
|
US20120157455A1
(en)
|
2009-09-02 |
2012-06-21 |
Canthera Therapeutics, Inc. |
Compounds And Compositions For Treating Cancer
|
|
US8318737B2
(en)
|
2009-09-02 |
2012-11-27 |
Canthera Therapeutics Inc. |
Compounds and compositions for treating cancer
|
|
US8349832B2
(en)
|
2009-09-02 |
2013-01-08 |
Canthera Therapeutics |
Compounds and compositions for treating cancer
|
|
WO2011080314A2
(en)
|
2009-12-31 |
2011-07-07 |
Deutsches Krebsforschungszentrum |
Novel modulators of trail signalling
|
|
CN101774875A
(zh)
|
2010-01-08 |
2010-07-14 |
北京欧凯纳斯科技有限公司 |
一种荜拔酰胺类化合物的合成方法
|
|
CN102125552A
(zh)
|
2010-01-20 |
2011-07-20 |
李绍路 |
荜茇酰胺衍生物在制备治疗癌症的药物中的用途及其药物组合物
|
|
CN102146054A
(zh)
|
2010-02-10 |
2011-08-10 |
新昌县来益科技开发有限公司 |
荜茇酰胺衍生物及其药物组合物和在制备抑制肿瘤生长的药物中的用途
|
|
WO2011130395A1
(en)
|
2010-04-13 |
2011-10-20 |
University Of Utah Research Foundation |
Inhibitors of flip to treat cancer
|
|
TWI620736B
(zh)
|
2010-11-23 |
2018-04-11 |
艾伯維巴哈馬有限公司 |
使用選擇性ｂｃｌ-２抑制劑之治療方法
|
|
SG192126A1
(en)
|
2011-01-25 |
2013-09-30 |
Univ Michigan |
Bcl-2/bcl-xl inhibitors and therapeutic methods using the same
|
|
US8940737B2
(en)
|
2011-10-14 |
2015-01-27 |
Abbvie Inc. |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
|
|
EP2602330A1
(en)
|
2011-12-07 |
2013-06-12 |
Palacky University, Olomouc |
Method of determination of cancer cell drug sensitivity towards Aurora kinase inhibitors and overcoming their resistance
|
|
CA2861066C
(en)
|
2012-01-12 |
2024-01-02 |
Yale University |
Compounds and methods for the enhanced degradation of targeted proteins and other polypeptides by an e3 ubiquitin ligase
|
|
EP2854809B1
(en)
|
2012-06-01 |
2017-12-06 |
Leibniz-Institut für Alternsforschung - Fritz-Lipmann-Institut e.V. (FLI) |
Inhibitors of the notch signalling pathway and secretion for use in medicine
|
|
US9108923B2
(en)
|
2012-07-20 |
2015-08-18 |
Howard Hughes Medical Institute |
Compounds, compositions, and methods for cancer therapy
|
|
CN103601670B
(zh)
|
2012-11-20 |
2016-06-15 |
中国人民解放军第二军医大学 |
荜拔酰胺类似物及其制备方法与应用
|
|
US10279018B2
(en)
|
2012-12-03 |
2019-05-07 |
Unity Biotechnology, Inc. |
Immunogenic compositions for inducing an immune response for elimination of senescent cells
|
|
GB201311910D0
(en)
|
2013-07-03 |
2013-08-14 |
Glaxosmithkline Ip Dev Ltd |
Novel Compounds
|
|
KR102318204B1
(ko)
*
|
2013-01-16 |
2021-10-26 |
더 리젠츠 오브 더 유니버시티 오브 미시간 |
Bcl-2bcl-xl 억제제 및 그를 사용하는 치료 방법
|
|
CN105377289A
(zh)
|
2013-04-21 |
2016-03-02 |
耶达研究及发展有限公司 |
用于下调Bcl-xL和/或Bcl-w的活性和/或量的试剂
|
|
AU2015211021B2
(en)
|
2014-01-28 |
2020-07-02 |
Buck Institute For Research On Aging |
Methods and compositions for killing senescent cells and for treating senescence-associated diseases and disorders
|
|
US10002107B2
(en)
|
2014-03-12 |
2018-06-19 |
D-Wave Systems Inc. |
Systems and methods for removing unwanted interactions in quantum devices
|
|
AU2015247817C1
(en)
|
2014-04-14 |
2022-02-10 |
Arvinas Operations, Inc. |
Imide-based modulators of proteolysis and associated methods of use
|
|
EP3139942B1
(en)
|
2014-05-05 |
2019-12-18 |
Bioventures, Llc |
COMPOSITIONS AND METHODS FOR INHIBITING ANTIAPOPTOTIC Bcl-2 PROTEINS AS ANTI-AGING AGENTS
|
|
US10071087B2
(en)
|
2014-07-22 |
2018-09-11 |
Bioventures, Llc |
Compositions and methods for selectively depleting senescent cells
|
|
US10071164B2
(en)
|
2014-08-11 |
2018-09-11 |
Yale University |
Estrogen-related receptor alpha based protac compounds and associated methods of use
|
|
US10552755B2
(en)
|
2014-08-22 |
2020-02-04 |
D-Wave Systems Inc. |
Systems and methods for improving the performance of a quantum processor to reduce intrinsic/control errors
|
|
US9694084B2
(en)
|
2014-12-23 |
2017-07-04 |
Dana-Farber Cancer Institute, Inc. |
Methods to induce targeted protein degradation through bifunctional molecules
|
|
US20180002431A1
(en)
|
2015-01-22 |
2018-01-04 |
Bioventures, Llc |
FAS AND DRs ARE NOVEL MOLECULAR TARGETS OF SENESCENT CELLS
|
|
WO2016118859A1
(en)
|
2015-01-22 |
2016-07-28 |
Board Of Trustees Of The University Of Arkansas |
Compositions and methods for selectively depleting senescent cells comprising flip
|
|
US20180000816A1
(en)
|
2015-02-06 |
2018-01-04 |
Unity Biotechnology, Inc. |
Use of a Heterocyclic Bcl-xL Inhibitor and Related Analogs for Removing Senescent Cells in the Treatment of Eye Diseases and Other Age-Related Conditions
|
|
WO2016182608A2
(en)
|
2015-02-10 |
2016-11-17 |
D-Wave Systems Inc. |
Systems, devices, articles, and methods for quantum processor architecture
|
|
US10730870B2
(en)
|
2015-03-18 |
2020-08-04 |
Arvinas Operations, Inc. |
Compounds and methods for the enhanced degradation of targeted proteins
|
|
CN107614020A
(zh)
*
|
2015-03-18 |
2018-01-19 |
免疫生化公司 |
靶向细胞内肿瘤相关抗原的用于治疗癌症的缀合物
|
|
CN105085620B
(zh)
|
2015-06-25 |
2018-05-08 |
中山大学附属第一医院 |
一种靶向泛素化降解Smad3的化合物
|
|
CA2993118A1
(en)
|
2015-07-21 |
2017-01-26 |
Fundacion Universidad Catolica De Valencia San Vicente Martir |
Combination comprising pterostilbene for the treatment of cancer
|
|
EP3337476A4
(en)
|
2015-08-19 |
2019-09-04 |
Arvinas, Inc. |
Compounds and methods for the targeted degradation of bromodomain-containing proteins
|
|
US11111259B2
(en)
*
|
2015-12-18 |
2021-09-07 |
Unity Biotechnology, Inc. |
Acylsulfonamide derivatives for treating senescence-associated diseases and disorders
|
|
US20190054097A1
(en)
|
2016-04-21 |
2019-02-21 |
Bioventures, Llc |
Compositions targeting senescent cells and the uses thereof
|
|
JP6936498B2
(ja)
*
|
2016-04-21 |
2021-09-15 |
バイオベンチャーズ・リミテッド・ライアビリティ・カンパニーＢｉｏＶｅｎｔｕｒｅｓ， ＬＬＣ |
抗アポトーシス性Ｂｃｌ−２ファミリータンパク質の分解を誘導する化合物及びその使用
|
|
US10296352B2
(en)
|
2016-06-15 |
2019-05-21 |
University Of Southern California |
Nested quantum annealing correction
|
|
EP3743069B1
(en)
|
2018-01-22 |
2025-08-06 |
BioVentures, LLC |
Bcl-2 proteins degraders for cancer treatment
|